OR WAIT null SECS
February 01, 2016
The Biosimilars Forum launched Partnership for Biosimilars Education and Access, an education initiative raising awareness of biosimilars in the US.
For successful partnerships, it’s important to take a long-term view, focus on simple designs, and address potential payer concerns up front.
The reporter bioassay, used to evaluate ADCC activity of therapeutic antibodies, complements the classical ADCC assay.
January 28, 2016
Hermes Pharma has commercially implemented hot-melt coating (HMC) technology at its production facility.
The agency is seeking industry input on product-specific recommendations to facilitate generic drug development.
NICE announces plans to back biosimilar alternatives to Merck’s Remicade.
January 13, 2016
The collaboration will focus on development of novel molecules using SMARTag technology to couple different therapeutic modalities.
January 04, 2016
BioPharm highlights the monoclonal antibodies that may gain United States regulatory approval in 2016.
January 02, 2016
Appropriate use of sound science applied at critical junctures will improve efficiency in the high-wire act of drug development.
January 01, 2016
Liquid formulations in hard-shell capsules or softgels are becoming a popular option for HPAPIs because of advantages such as improved safety and lower risk of potential exposure and product cross contamination.